Cho, H. J., Shin, H.-W., Panyakaew, P., Kassavetis, P., Popa, T., Wu, T., Leodori, G., Camacho, T., Singh, S., Meunier, S., & Hallett, M. (2024). Differential induction of Parieto-motor plasticity in writer’s cramp and cervical dystonia. Neurobiology of Disease, 202, 106724. https://doi.org/10.1016/j.nbd.2024.106724

Kanade-Mehta, P., Bengtson, M., Stoeckmann, T., McGuire, J., Ghez, C., & Scheidt, R. A. (2023). Spatial mapping of posture-dependent resistance to passive displacement of the hypertonic arm post-stroke. Journal of NeuroEngineering and Rehabilitation, 20(1). https://doi.org/10.1186/s12984-023-01285-7

Kim, M. S., Cleymaet, S. V., Kim, S., Andres, J., Ruchalski, C., Kim, Y., Azizi, S. A., Sharrief, A. Z., & Naqvi, I. A. (2022). Interdisciplinary patient-centred poststroke care in Follow-up After Stroke, Screening and Treatment (FASST) clinic model: a proof-of-concept pilot study. Integrated Healthcare Journal, 4(1). https://doi.org/10.1136/ihj-2021-000118

Lin, C. R., Amokrane, N., Chen, S., Chen, T. X., Lai, R., Trinh, P., Minyetty, M. J., Emmerich, H., Pan, M., Claassen, D. O., & Kuo, S. (2022). Cerebellar impulsivity–compulsivity assessment scale. Annals of Clinical and Translational Neurology, 10(1), 48–57. Portico. https://doi.org/10.1002/acn3.51698

Sun, L., Tong, C.-K., Morgenstern, T. J., Zhou, H., Yang, G., & Colecraft, H. M. (2022). Targeted ubiquitination of sensory neuron calcium channels reduces the development of neuropathic pain. Proceedings of the National Academy of Sciences, 119(20). https://doi.org/10.1073/pnas.2118129119

Reyes, F. I., Shoval, H. A., Tenaglia, A., & Kim, H. (2022). Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy. Toxins, 14(3), 158. https://doi.org/10.3390/toxins14030158

Dimitrova, R., Kim, H., Meilahn, J., Chambers, H. G., Racette, B. A., Bonikowski, M., Park, E. S., McCusker, E., Liu, C., & Brin, M. F. (2022). Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial. NeuroRehabilitation, 50(1), 33–46. https://doi.org/10.3233/nre-210070